Skip to main content

Table 5 Outcomes at baseline and 1 year follow-up

From: Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries

 

Adherence therapy (n = 204)

Health education (n = 205)

Adherence therapy – Health education1

Valid n

Mean

(SD)

Valid n

Mean

(SD)

Unadjusted comparisons

Baseline-adjusted comparisons

Mean difference

95% confidence interval

Mean difference

95% confidence interval

SF-36 MCS

Baseline

191

38.39

(11.22)

195

40.11

(12.15)

-1.72

-4.14, 0.54

na

na

1 year follow-up

175

40.24

(11.97)

192

41.32

(11.49)

-1.08

-3.43, 1.42

-0.33

-2.41, 1.79

SF-36 utilities and QALYs

Baseline utility

191

0.66

(0.12)

192

0.68

(0.13)

-0.02

-0.04, 0.01

na

na

1 year follow-up utility

177

0.68

(0.14)

190

0.69

(0.13)

-0.01

-0.04, 0.02

-0.005

-0.03, 0.02

1 year QALY gain

166

0.67

(0.11)

179

0.68

(0.12)

-0.01

-0.04, 0.01

-0.002

-0.01, 0.01

EQ5D utilities and QALYs

Baseline utility

196

0.67

(0.30)

198

0.69

(0.28)

-0.02

-0.08, 0.03

na

na

1 year follow-up utility

174

0.68

(0.31)

193

0.74

(0.26)

-0.06

-0.12, -0.003

-0.04

-0.09, 0.01

1 year QALY gain

170

0.67

(0.26)

188

0.72

(0.23)

-0.05

-0.10, 0.01

-0.02

-0.05, 0.01

  1. 1. Based on bootstrapped linear regression of group upon cost (1000 repetitions).
  2. na = not applicable to baseline comparisons.